Pluripotent Stem Cell Differentiation via Phagocytosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for differentiating pluripotent stem cells into various cell types are complex, time-consuming, and often result in tumorigenicity, making it difficult to produce homogeneous and functional cells efficiently.
Innovation Solution
Co-culturing pluripotent stem cells with damaged or dead cells, which induces differentiation through phagocytosis, allowing the cells to acquire the phenotype and function of the original damaged cells, thereby simplifying the process and reducing the risk of tumorigenicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods (multiple steps, cytokine administration) are used to differentiate pluripotent stem cells, then differentiation can be achieved, but the process becomes complicated and time-consuming
Solution Approach 1:
The patent extracts and utilizes the phagocytic function of pluripotent stem cells as the key mechanism for differentiation. By focusing on this single intrinsic capability rather than multiple external factors (cytokines, growth factors, complex media), the method simplifies the differentiation process while maintaining effectiveness. The phagocytic uptake of damaged cells provides direct informational cues that guide differentiation without requiring complex signaling pathways.
Solution Approach 2:
The pluripotent stem cells utilize their own phagocytic function to achieve differentiation. The cells themselves provide the mechanism for receiving differentiation signals through phagocytosis of damaged cells, eliminating the need for external cytokine administration or complex culture conditions. This self-service approach reduces process complexity while maintaining differentiation reliability.
2Reliability
If conventional differentiation methods are used, then cell differentiation can be induced, but the process requires long term period (several weeks)
Solution Approach 1:
The patent employs preliminary action by pre-damaging cells to create phagocytic targets before introducing pluripotent stem cells. The damaged cells are prepared in advance and used as immediate differentiation cues, eliminating the need for prolonged waiting periods. This preliminary preparation of differentiation signals accelerates the overall process while maintaining differentiation effectiveness.
Solution Approach 2:
By extracting and utilizing the phagocytic function as the primary differentiation mechanism, the patent eliminates the need for prolonged exposure to multiple cytokines and growth factors. The direct phagocytic uptake of damaged cells provides immediate differentiation cues, significantly reducing the time required compared to conventional methods that rely on gradual signaling and cell cycle progression.
3Reliability
If conventional differentiation methods are used, then purposive cells can be produced, but the process is costly
Solution Approach 1:
The patent utilizes damaged and dead cells as disposable phagocytic targets that provide differentiation cues without requiring expensive maintenance. These cells are prepared once and then used to induce differentiation in pluripotent stem cells, eliminating the need for continuous expensive cytokine supplementation or complex media changes. The damaged cells serve their purpose and are discarded, reducing overall production costs.
Solution Approach 2:
The method relies on the intrinsic phagocytic function of pluripotent stem cells to achieve differentiation, eliminating the need for expensive external differentiation factors. The cells differentiate through their own phagocytic activity upon contact with damaged cells, reducing dependency on costly cytokines, growth factors, and complex culture conditions while maintaining production quality.
4Adaptability or versatility
If exogenous gene introduction is used to achieve pluripotency, then iPS cells can be generated, but tumor genicity risk increases
Solution Approach 1:
The patent extracts and utilizes the natural phagocytic function of pluripotent stem cells to achieve differentiation without relying on exogenous gene introduction. By focusing on the intrinsic phagocytic mechanism rather than external genetic manipulation, the method eliminates the tumor genicity risks associated with iPS cell generation while maintaining pluripotency and differentiation capability.
Solution Approach 2:
The patent uses damaged cells as informational templates that are copied into the pluripotent stem cells through phagocytosis. The differentiation information is transferred via phagocytic uptake of cellular components from damaged cells, eliminating the need for exogenous gene introduction. This copying of functional information rather than genetic material avoids tumor genicity risks.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the efficient production of homogeneous, functional cells with reduced tumorigenic risk, suitable for regenerative medicine, pharmaceutical development, and safety testing, by leveraging the phagocytic properties of pluripotent stem cells to differentiate into specific cell types.
Implementation Method 1
the method is based on subjecting cells to feeder-less culture, isolating the cells as single cells, and thereafter, plating the cells at high density, and then conducting adhesion culture
Data Source
AI summary
The purpose of the present invention is to provide a cell creation method that enables a reduction in cost and time, that is highly safe, and that has great potential for being industrially applied. Provided by the present invention is a method for inducing differentiation of pluripotent cells in vitro into cells having a same phenotype and function as information-presentation cells, the method comprising co-culturing pluripotent cells or a cellular fraction having said pluripotent cells concentrated therein, together with damaged cells or dead cells derived from information-presentation cells, or together with a portion of the damaged cells or dead cells derived from information-presentation cells.